99Tcm-MIBI显像检测乳腺癌多药耐药

The appliciation of 99Tcm-MIBI scintimammography to diagnose multidrug resistance of breast cancer

  • 摘要: 探讨了乳腺癌组织的多药耐药现象的主要机制及P-糖蛋白(P-gp)、胎盘型谷胱甘肽硫转移酶(GST-π)与99Tcm-MIBI显像的关系。尽管文献报道的实验结果不尽相同,但作为一种功能显像技术,99Tcm-MIBISPECT显像能够用来研究乳腺癌细胞P-gp的表达,可以在体外无创性检测乳腺癌多药耐药,为指导乳腺癌的治疗提供参考。

     

    Abstract: This article discussed the main mechanism of multidrug resistance of breast cancer tissues, and the correla-tion between technetium-99m sestamibi (99Tcm-MIBI) breast imaging results, with the expression of drug resistance pro-teins P-glycoprotein and glutathione-S-transfease-π in human breast cancer.Though not all the results reported before matched each other, as a kind of a noninvasive simple functional test imaging technology in vitro, SPECT can be used to diagnose P-glycoprotein expression in breast cancer, and can be used to predict chemotherapy response.

     

/

返回文章
返回